The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry &amp; molecular intervention (Q37855840)

24 August 2017

1 reference

title

The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention (English)

1 reference

Mycobacterium tuberculosis

24 August 2017

main subject

0 references

physiology

0 references

author name string

Kirsty J McLean

1

1 reference

24 August 2017

James Belcher

2

1 reference

24 August 2017

Max D Driscoll

3

1 reference

24 August 2017

Christine C Fernandez

4

1 reference

24 August 2017

Duyet Le Van

5

1 reference

24 August 2017

Soi Bui

6

1 reference

24 August 2017

Marina Golovanova

7

1 reference

24 August 2017

Andrew W Munro

8

1 reference

24 August 2017

publication date

1 August 2010

1 reference

Future Medicinal Chemistry

24 August 2017

published in

1 reference

24 August 2017

volume

2

1 reference

24 August 2017

issue

8

1 reference

24 August 2017

page(s)

1339-1353

1 reference

Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Extensively drug-resistant tuberculosis: a new face to an old pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

PA-824 kills nonreplicating Mycobacterium tuberculosis by intracellular NO release

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

New insights into the early steps of phosphatidylinositol mannoside biosynthesis in mycobacteria: PimB' is an essential enzyme of Mycobacterium smegmatis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Mycobacterial Ser/Thr protein kinases and phosphatases: physiological roles and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

The preponderance of P450s in the Mycobacterium tuberculosis genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Neutral thiol as a proximal ligand to ferrous heme iron: implications for heme proteins that lose cysteine thiolate ligation on reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Variations on a (t)heme--novel mechanisms, redox partners and catalytic functions in the cytochrome P450 superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cytochrome p450 and chemical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Biodiversity of cytochrome P450 redox systems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cytochrome P450/redox partner fusion enzymes: biotechnological and toxicological prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

The past and present of P450cam structural biology

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Structure of cytochrome P450eryF: substrate, inhibitors, and model compounds bound in the active site.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

EpoK, a cytochrome P450 involved in biosynthesis of the anticancer agents epothilones A and B. Substrate-mediated rescue of a P450 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Structural characterization of a novel sulfated menaquinone produced by stf3 from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cytochrome P450 and the individuality of species

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Mycobacterium tuberculosis Rv1395 is a class III transcriptional regulator of the AraC family involved in cytochrome P450 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

An update on antifungal targets and mechanisms of resistance in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Advances in antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Crystal structure of cytochrome P450 14 -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Genes required for mycobacterial growth defined by high density mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Genetic requirements for mycobacterial survival during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Small-Molecule Scaffolds for CYP51 Inhibitors Identified by High-Throughput Screening and Defined by X-Ray Crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Mycobacterial cytochrome p450 125 (cyp125) catalyzes the terminal hydroxylation of c27 steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

What do microarrays really tell us about M. tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Mycobacterial persistence requires the utilization of host cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cholesterol-sensor initiates M. tuberculosis entry into human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

The surface of lipid droplets is a phospholipid monolayer with a unique Fatty Acid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Essential role for cholesterol in entry of mycobacteria into macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

A thiolase of Mycobacterium tuberculosis is required for virulence and production of androstenedione and androstadienedione from cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Coronin-1A epigenomics governs mycobacterial persistence in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cholesterol metabolism increases the metabolic pool of propionate in Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Characterization of mycobacterial virulence genes through genetic interaction mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

The actinobacterial mce4 locus encodes a steroid transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Characterization of a Carbon-Carbon Hydrolase from Mycobacterium tuberculosis Involved in Cholesterol Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

3-Ketosteroid 9alpha-hydroxylase is an essential factor in the pathogenesis of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Identification of Mycobacterial genes that alter growth and pathology in macrophages and in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

igr Genes and Mycobacterium tuberculosis cholesterol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Transcriptomic analysis identifies growth rate modulation as a component of the adaptation of mycobacteria to survival inside the macrophage.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cytochrome P450 125 (CYP125) catalyses C26-hydroxylation to initiate sterol side-chain degradation in Rhodococcus jostii RHA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Rapid and spontaneous loss of phthiocerol dimycocerosate (PDIM) from Mycobacterium tuberculosis grown in vitro: implications for virulence studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Expression, purification and spectroscopic characterization of the cytochrome P450 CYP121 from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Structure and chemistry of cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cyclodipeptide synthases are a family of tRNA-dependent peptide bond-forming enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Identification and structural basis of the reaction catalyzed by CYP121, an essential cytochrome P450 in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Characterization of Active Site Structure in CYP121: A CYTOCHROME P450 ESSENTIAL FOR VIABILITY OF MYCOBACTERIUM TUBERCULOSIS H37Rv

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

A postgenomic method for predicting essential genes at subsaturation levels of mutagenesis: application to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Functional and evolutionary genomics of Mycobacterium tuberculosis: insights from genomic deletions in 100 strains

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Gene expression diversity among Mycobacterium tuberculosis clinical isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Mycobacterium tuberculosis CYP130: CRYSTAL STRUCTURE, BIOPHYSICAL CHARACTERIZATION, AND INTERACTIONS WITH ANTIFUNGAL AZOLE DRUGS

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Interaction of Mycobacterium tuberculosis CYP130 with Heterocyclic Arylamines

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Cytochrome P450 activation of arylamines and heterocyclic amines

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Biochemical and structural characterization of CYP124: A methyl-branched lipid -hydroxylase from Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Managing TB in the 21st century: existing and novel drug therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

The potential of azole antifungals against latent/persistent tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Synthesis and antitubercular screening of imidazole derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Azole resistance in Mycobacterium tuberculosis is mediated by the MmpS5-MmpL5 efflux system

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

New generation azole antifungals in clinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

Estriol bound and ligand-free structures of sterol 14alpha-demethylase

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

After decades of drought, new drug possibilities flood TB pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.216

21 January 2018

Identifiers

DOI

10.4155/FMC.10.216

1 reference

24 August 2017

1 reference